Literature DB >> 12202971

Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice.

Brian Gilliss1, C J Malanga, Jeanne O Pieper, William A Carlezon.   

Abstract

RATIONALE: The dopamine D(1)-like receptor agonist SKF-82958 reportedly blocks reinstatement of cocaine-seeking behavior in rats and non-human primates. It is not known if SKF-82958 reduces drug-seeking behaviors in animals exposed previously to cocaine by causing reward-like effects or withdrawal-like aversive effects.
OBJECTIVES: Intracranial self-stimulation (ICSS) studies were conducted to determine if SKF-82958 has reward-like or withdrawal-like effects in mice exposed previously to cocaine, or under the influence of cocaine at the time of testing.
METHODS: Swiss-Webster mice with lateral hypothalamic stimulating electrodes were trained to self-administer rewarding brain stimulation. The mice were tested in a "curve-shift" variant of the ICSS procedure after intraperitoneal administration of cocaine alone (2.5-20 mg/kg), SKF-82958 alone (0.03-0.3 mg/kg), or a mixture of both drugs (SKF 0.03 mg/kg + 2.5 or 5.0 mg/kg cocaine). Each treatment was given twice.
RESULTS: Cocaine and SKF-82958 each caused dose-dependent decreases in brain stimulation reward thresholds that were largest immediately after administration. A dose of SKF-82958 with no reward-related effects of its own potentiated the reward-related effects of low doses of cocaine. Repeated administration did not cause progressive changes in the ability of any treatment to decrease thresholds.
CONCLUSIONS: Cocaine and SKF-82958 each potentiate the rewarding effects of lateral hypothalamic brain stimulation in Swiss-Webster mice, implying that these drugs have rewarding effects of their own. The reward-facilitating effects of low doses of cocaine and SKF-82958 are additive (or synergistic). These data suggest that SKF-82958 may decrease cocaine-seeking behavior by mechanisms related to reward rather than aversion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202971     DOI: 10.1007/s00213-002-1153-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 2.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

3.  Opposing effects of dopamine D1- and D2-like agonists on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; Luke P Legakis; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2016-03-17       Impact factor: 3.157

4.  Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

Authors:  Aaron Ettenberg; Rick E Bernardi
Journal:  Pharmacol Biochem Behav       Date:  2006-10-24       Impact factor: 3.533

5.  N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.

Authors:  Matthew D Puhl; Rajeev I Desai; Shunsuke Takagi; Kendall T Presti; Michelle R Doyle; Rachel J Donahue; Samantha M Landino; Jack Bergman; William A Carlezon; Joseph T Coyle
Journal:  Addict Biol       Date:  2017-11-23       Impact factor: 4.280

6.  Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.

Authors:  G I Elmer; J O Pieper; J Levy; M Rubinstein; M J Low; D K Grandy; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

7.  ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488.

Authors:  John W Muschamp; Christina L Nemeth; Alfred J Robison; Eric J Nestler; William A Carlezon
Journal:  Biol Psychiatry       Date:  2011-09-29       Impact factor: 13.382

8.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

9.  Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice.

Authors:  Eric W Fish; Thorfinn T Riday; Megan M McGuigan; Sara Faccidomo; Clyde W Hodge; C J Malanga
Journal:  Alcohol Clin Exp Res       Date:  2009-10-23       Impact factor: 3.455

10.  Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum.

Authors:  Elena H Chartoff; Maria Papadopoulou; Christine Konradi; William A Carlezon
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.